Physician profile
Peter W Bailey
NPI 1982617502
$9,745.51
in general payments reported to CMS, 2019-2025
11 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $1,359 · 2021: $1,015 · 2022: $2,633 · 2023: $808 · 2024: $2,099 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,267.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,715.84 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Relievant Medsystems, INC. | $1,188.74 | 2019-2023 | Intracept |
| Medtronic, INC. | $209.53 | 2022-2023 | Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $164.19 | 2025 | Senza |
| Nalu Medical, INC. | $153.98 | 2023 | Nalu Neurostimulation System |
| Sonex Health, INC. | $144.23 | 2021-2022 | |
| Spr Therapeutics, INC | $74.26 | 2024-2025 | Sprint Pns System |
| Novo Nordisk INC | $34.56 | 2025 | Ozempic |
| Nevro Corp. | $31.70 | 2024 | Senza |
| Vericel Corporation | $17.25 | 2024 | Maci |
| Vertiflex, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.